|
|
News Breaks | | | | October 23, 2012 | | 07:39 EDT |  | CYTX | Cytori Therapeutics initiates cell therapy clinical study for scleroderma
Cytori Therapeutics announced that an investigator-sponsored and funded clinical study evaluating Cytori’s cell therapy as a potential treatment for limited and diffuse cutaneous systemic sclerosis has been approved to begin in France by the National Agency for the Safety of Medicines and Health Products. The primary endpoints are safety and the improvement in function of the hands, as measured by the Cochin hand functional scale at six months. Secondary endpoints include severity of pain visual analog scale, Systemic Sclerosis Health Assessment Questionnaire, Rodnan score adapted to the hand, HAMIS test, and severity of the Raynaud’s syndrome. The first patient in the study is expected to be treated in November. | |
|
News For CYTX From The Last 14 Days Check below for free stories on CYTX the last two weeks. |
|
|
| May 9, 2013 | | 16:07 EDT |  | CYTX | Cytori Therapeutics reports Q1 EPS (11c), consensus (15c)
 Subscribe for More Information | |
|
|
|
|
|
|
